Ara-290

Ara-290 is an artificially synthesized small molecule active peptide (derived from the non-hematopoietic domain of erythropoietin EPO). Its core efficacy focuses on anti-inflammation, tissue repair and neuroprotection, and it does not have the traditional erythropoietin-induced proliferation effect on red blood cells (avoiding the risk of anemia). It is suitable for the auxiliary intervention of inflammatory-related diseases, tissue damage repair and neurodegenerative diseases. Relevant pharmacological research and early clinical evidence have clearly demonstrated its targeted effect.